Vitalsource Technologies, Inc. Reprogramming The Genome: Crispr-cas-based Human Disease Therapy

Sponsored  This site contains affiliate links for which we may receive compensation. More information

Sponsored Vitalsource Technologies, Inc. Reprogramming The Genome: Crispr-cas-based Human Disease Therapy

171.00 USD
Price updated on: 13-11-2024 12:01:25
View product deal
Identifiers
Dimensions / Weight
Key Features
Elsevier Science & Techn.